Reply: Post-Percutaneous Coronary Intervention Angina: A New Performance Measure?
Clemens
C
von Birgelen
Liefke C
LC
van der Heijden
Hanim
H
Sen
Marije M
MM
Löwik
D002317:Cardiovascular Agents / Q000008:administration & dosage*; D003324:Coronary Artery Disease / Q000628:therapy*; D054855:Drug-Eluting Stents; D000068338:Everolimus / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000295:instrumentation*; D011108:Polymers; D020123:Sirolimus / Q000031:analogs & derivatives*
D002317:Cardiovascular Agents; D011108:Polymers; D000068338:Everolimus; D020123:Sirolimus